Johnson & Johnson’s Janssen unit will begin mid-stage trials of its COVID-19 vaccine in Spain on Monday, the program’s lead investigator said.
Alberto Borobia said 190 people would take part in the country’s trials, which will take place in three hospitals and be concluded by Sept. 22.
For more coronavirus news, visit our dedicated page.
The Spanish study is part of mid-stage, or Phase II, trials of the vaccine that are being carried out in three countries, also including the Netherlands and Germany.
The trials in the three countries will last two months and include 550 participants in total.
On Saturday, it was announced that British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed after they were suspended this week following an illness in a study subject in Britain.
Coronavirus: Brazilian state of Bahia to test Russia’s vaccine, to buy 50 mln dosesThe Brazilian state of Bahia has signed an agreement to conduct Phase III clinical trials of Russia's Sputnik V vaccine against COVID-19 and plans to ... Coronavirus
Coronavirus: White House adviser Dr. Fauci sticks with projection of vaccine in 2021The White House adviser on the coronavirus Dr. Anthony Fauci says he’s sticking with his projection that a safe and effective coronavirus vaccine may ... Coronavirus
World’s first Phase III COVID-19 vaccine trials in UAE reaches 31,000 volunteersThe first Phase III trials -- named 4Humanity trials -- of an inactivated vaccine for COVID-19 in the United Arab Emirates are among the largest in ... Coronavirus